Nykredit A/S’s LeMaitre Vascular LMAT Stock Holding History

Nykredit A/S’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.3K	Buy	+858	New	+$88K	﹤0.01%	1378

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Nykredit A/S's LMAT Position: Q2 2026 in Review

Nykredit A/S opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 858 shares worth $82.3K. The stake represents ﹤0.01% of the portfolio and ranks #1378 among its holdings.

255 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Nykredit A/S held 858 shares of LeMaitre Vascular worth $82.3K as of Q2 2026.
LeMaitre Vascular was a new Nykredit A/S position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1378 holding.
255 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.